Free Trial
CVE:SVS

Solarvest BioEnergy (SVS) Stock Price, News & Analysis

Solarvest BioEnergy logo
C$0.02 0.00 (0.00%)
As of 09/5/2023

About Solarvest BioEnergy Stock (CVE:SVS)

Key Stats

Today's Range
C$0.02
C$0.03
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.01
C$0.14
Volume
3,159 shs
Average Volume
77,594 shs
Market Capitalization
C$1.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

SVS Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Solarvest Sells PEI Facility
See More Headlines

SVS Stock Analysis - Frequently Asked Questions

Solarvest BioEnergy's stock was trading at C$0.03 on January 1st, 2025. Since then, SVS stock has increased by 0.0% and is now trading at C$0.03.

Shares of SVS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solarvest BioEnergy investors own include FSD Pharma (HUGE), Nemaska Lithium (NMX), Intercept Pharmaceuticals (ICPT), Sernova (SVA), Routemaster Capital Inc. (RM.V) (RM), IGEN Networks (IGEN) and Clean Energy Pathways (CPWY).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SVS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.26 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$740.00
Cash Flow
C$0.00 per share
Price / Cash Flow
55.00
Book Value
C($0.10) per share
Price / Book
-0.25

Miscellaneous

Free Float
N/A
Market Cap
C$1.52 million
Optionable
Not Optionable
Beta
1.50
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (CVE:SVS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners